Press Release

PhRMA Statement on the Passing of Sen. Ted Kennedy

PhRMA August 26, 2009

Washington, D.C. (August 26, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO Billy Tauzin issued the following statement today regarding the death of Sen. Ted Kennedy:

“We share the nation’s sadness in mourning the loss of Senator Ted Kennedy, a lifelong champion for health whose leadership on such monumental legislation as the State Children’s Health Insurance Program and the Americans With Disabilities Act leaves a lasting legacy that benefits the nation as a whole.

“Over nearly five decades, Sen. Kennedy has been a powerful force for good with few peers. As a leader and legislator, he appreciated the importance of medical progress for patients here and around the world.

“Like the rest of the nation, we are grateful for Sen. Kennedy’s decades of service to this nation. We have truly lost a remarkable gentleman and Congressional giant.”

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address:

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For more information on public health emergencies, visit

For information on the danger of imported drugs, visit: